Seroatlas · Human Serome Atlas

DR1

Protein Dr1

Also known as: NC2-BETA, NC2B, NC2B_HUMAN, NCB2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q01658
Gene
DR1
Ensembl
ENSG00000117505
Chromosome
1
Canonical length
176 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nucleoplasm
Quaternary structure
Homotetramer

OverviewNCBI Gene

This gene encodes a TBP- (TATA box-binding protein) associated phosphoprotein that represses both basal and activated levels of transcription. The encoded protein is phosphorylated in vivo and this phosphorylation affects its interaction with TBP. This protein contains a histone fold motif at the amino terminus, a TBP-binding domain, and a glutamine- and alanine-rich region. The binding of DR1 repressor complexes to TBP-promoter complexes may establish a mechanism in which an altered DNA conformation, together with the formation of higher order complexes, inhibits the assembly of the preinitiation complex and controls the rate of RNA polymerase II transcription. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

176 residues, UniProt reviewed canonical sequence.

>Q01658|DR1
     1  MASSSGNDDD LTIPRAAINK MIKETLPNVR VANDARELVV NCCTEFIHLI SSEANEICNK
    61  SEKKTISPEH VIQALESLGF GSYISEVKEV LQECKTVALK RRKASSRLEN LGIPEEELLR
   121  QQQELFAKAR QQQAELAQQE WLQMQQAAQQ AQLAAASASA SNQAGSSQDE EDDDDI

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against DR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.47
Highest tissue expression
56 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 56 nTPM
  • testis: 52 nTPM
  • skeletal muscle: 47 nTPM
  • thymus: 44 nTPM
  • lymph node: 41 nTPM
  • tongue: 40 nTPM

Single-cell type

  • late primary spermatocytes: 283 nCPM
  • megakaryocytes: 185 nCPM
  • basal keratinocytes: 149 nCPM
  • neutrophil progenitors: 148 nCPM
  • early spermatids: 148 nCPM
  • late spermatids: 137 nCPM

Immune cell

  • basophil: 96 nTPM
  • eosinophil: 82 nTPM
  • neutrophil: 63 nTPM
  • T-reg: 57 nTPM
  • myeloid DC: 56 nTPM
  • intermediate monocyte: 53 nTPM

Brain region

  • choroid plexus: 63 nTPM
  • cerebellum: 38 nTPM
  • hypothalamus: 36 nTPM
  • thalamus: 35 nTPM
  • white matter: 34 nTPM
  • spinal cord: 34 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.37
gnomAD pLI
0.92
gnomAD missense Z
2.23
DepMap mean gene effect
-0.88
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of DR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads DR1 as an antibody target. Whether an autoantibody or antibody against DR1 could matter depends on whether native DR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

DR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label DR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/DR1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...